| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 15 | 0.422 | 0.846 | 0.71 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2017 | ||||||||
|
sphingosine-1-phosphate receptor 1 | 0.546 | 0.769 | 0.73 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
microRNA 29a | 0.459 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2017 | |||||||||
|
eukaryotic translation initiation factor 2 alpha kinase 2 | 0.538 | 0.769 | 1.8E-02 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2001 | 2018 | ||||||||
|
ROS proto-oncogene 1, receptor tyrosine kinase | 0.439 | 0.885 | 1.6E-72 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2020 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2018 | ||||||||
|
mitogen-activated protein kinase 8 | 0.397 | 0.885 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2019 | |||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2019 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2019 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
mixed lineage kinase domain like pseudokinase | 0.570 | 0.731 | 2.1E-14 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2019 | ||||||||
|
interferon lambda 1 | 0.599 | 0.654 | 2.8E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2017 | ||||||||
|
formyl peptide receptor 2 | 0.547 | 0.769 | 0.40 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
cytokine inducible SH2 containing protein | 0.500 | 0.808 | 5.4E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2018 | ||||||||
|
cholinergic receptor muscarinic 3 | 0.464 | 0.885 | 0.99 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2019 | ||||||||
|
interleukin 24 | 0.498 | 0.769 | 5.9E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2016 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2018 | ||||||||
|
dual oxidase 2 | 0.533 | 0.769 | 4.5E-56 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2015 | 2018 | ||||||||
|
receptor interacting serine/threonine kinase 3 | 0.497 | 0.885 | 1.2E-14 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2018 | ||||||||
|
endogenous retrovirus group K member 32, envelope | 0.522 | 0.692 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2020 | |||||||||
|
interleukin 32 | 0.495 | 0.731 | 3.7E-09 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2015 | ||||||||
|
C-X-C motif chemokine ligand 10 | 0.378 | 0.885 | 0.37 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2018 | ||||||||
|
endogenous retrovirus group K member 6, envelope | 0.521 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2020 | |||||||||
|
nuclear receptor subfamily 1 group I member 2 | 0.418 | 0.846 | 7.3E-09 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 |